FOXO Technologies Inc. (FOXO) KPIs and segments
Close on Oct 19, 2026Market cap –P/E –Yield –
KPIs & segments
Operating metrics and segments that drive FOXO Technologies's business
FOXO Technologies's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Health Cares($M) | 4.47 | 4.80 | 4.21 | 3.51 | 5.21 | 3.16 | 2.81 | 1.19 | 0.02 | ||||
Life Science Services($M) | 0.24 | 0.36 | 0.22 | 0.03 | |||||||||
Labs($M) | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Corporate Segment and Other Operating Segment($M) | 0.00 | ||||||||||||
Earlier reporting (last reported 2025)1 | |||||||||||||
Management Contingent Share Plan Forfeiture Expense($M) | 9.13 | -0.02 | |||||||||||
Gain On Legal Settlement($M) | 1.65 | ||||||||||||
Labs($M) | -0.02 | -0.03 | -0.05 | -0.07 | -0.03 | -0.02 | 0.11 | -0.38 | -0.71 | ||||
Life Science Services($M) | -0.19 | 0.14 | -0.12 | -0.00 | |||||||||
Health Cares($M) | -0.44 | 0.30 | -8.59 | -0.76 | 1.29 | -0.84 | -1.58 | -0.05 | -0.07 | ||||
Corporate And Others($M) | -0.68 | -0.75 | |||||||||||
Corporate Segment and Other Operating Segment($M) | -0.87 | -0.07 | -0.10 | -0.77 | -0.72 | -3.21 | -0.56 | -0.84 | -1.04 | -7.92 | -3.10 | ||
Interest Expenses($M) | -1.31 | -1.01 | |||||||||||
Earlier reporting (last reported 2025)1 | |||||||||||||
Health Cares($M) | 42.1 | 41.8 | 40.9 | 48.5 | 49.6 | 46.8 | 41.4 | 40.0 | 4.34 | ||||
Life Science Services($M) | 3.67 | 3.83 | 3.65 | 2.97 | |||||||||
Corporate Segment and Other Operating Segment($M) | 0.10 | 0.11 | 0.04 | 0.64 | 0.37 | 0.20 | 0.28 | 0.49 | 0.13 | 0.32 | |||
Labs($M) | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | |||||||
Earlier reporting (last reported 2025)1 | |||||||||||||
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-08-14.
See a number that looks wrong?